| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biogen Inc. (BIIB) has 15 insiders with recent SEC Form 4 filings, including 4 buys and 7 sells. BIIB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 31.0K | $6.34M | - | |
| Dir | 24.3K | $4.98M | - | |
| Dir | 13.7K | $2.80M | - | |
| Dir | 9.8K | $2.00M | - | |
| Dir | 8.9K | $1.81M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 25, 2017 | Alexander Susan H | EVP Chief Legal Corp Svc &Sec | Sell | 4,974 | $290.01 | $1,442,509.74 | -18.3% | |
| Jul 19, 2017 | Alexander Susan H | EVP Chief Legal Corp Svc &Sec | Sell | 7,758 | $285.00 | $2,211,030.00 | -22.2% | |
| Jun 9, 2017 | Posner Brian S59 | Director | Sell | 1,084 | $256.31 | $277,840.04 | -14.6% | |
| May 1, 2017 | Vounatsos Michel | Chief Executive Officer | Buy | 1,402 | $271.35 | $380,432.70 | +91.9% | |
| Apr 27, 2017 | Denner Alexander J66 | Director | Buy | 73,858 | $278.50 | $20,569,475.84 | +11.6% | |
| Apr 25, 2017 | Clancy Paul J | Executive VP And CFO | Sell | 9,892 | $290.00 | $2,868,680.00 | -47.8% | |
| Apr 3, 2017 | Sandrock Alfred67 | EVP CMO Neuro &Neurodegenerat | Sell | 1,981 | $274.08 | $542,952.48 | -21.9% | |
| Mar 13, 2017 | Clancy Paul J | Executive VP And CFO | Sell | 9,891 | $291.55 | $2,883,721.05 | -32.3% | |
| Mar 1, 2017 | Sandrock Alfred67 | EVP CMO Neuro &Neurodegenerat | Sell | 973 | $290.07 | $282,238.11 | -9.7% | |
| Feb 27, 2017 | Vounatsos Michel | Chief Executive Officer | Buy | 1,333 | $285.39 | $380,424.87 | +1,321% |